CarboCode logo

CarboCode

Healthcare & Life Sciences

Recent Finacing

Series C

Recent Raise

$15.6M


CarboCode is a biotechnology company developing a platform for large-scale production of glycosphingolipids and gangliosides to enhance cognition, inflammation modulation, and gut health.

Total Funding

$15.6M

Headquarters

Cantanhede, Portugal

Founded

N/A

Focus Areas

Biotechnology
Glycosphingolipids
Gangliosides
Cognition
Inflammation
Gut Health

Investors

Iberis Capital logo